BeStock  
Stocks › Biotechnology › OCS

Oculis OCS

US equityMarket cap rank #3711Biotechnology
$8.50 −$0.22 (-2.52%)
Pre-market · Oct 8, 7:40 am ET · After hours $8.50 0.00%
Open$8.83
Prev close$8.72
Day range$8.35 – $8.83
Volume173.7K
Market cap$523.50M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-11.9%BearishTrading below the 20-day average of $9.64
Price vs 50-day average-24.9%BearishTrading below the 50-day average of $11.31
Price vs 200-day average-57.4%BearishTrading below the 200-day average of $19.95
50-day vs 200-day50d below 200dBearishThe 50-day average is below the 200-day average
RSI (14)26.0NeutralOversold territory (30 or below); selling this heavy often eases
MACD (12,26,9)-0.84BearishMACD line is below its signal line
Bollinger band position15%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$9.64-11.9%
50-day SMA$11.31-24.9%
200-day SMA$19.95-57.4%

Recent price levels

LevelPrice
20-day high$11.98
20-day low$8.30
60-day high$13.70
60-day low$8.30
Upper Bollinger band$11.27
Lower Bollinger band$8.02

The 50-day average is currently 43.3% below the 200-day average — consistent with a “death cross” (bearish) configuration.

30-day volatility47.8%
Average true range6.37% of price
Max drawdown (1y)-74.0%
Volume (10d vs 90d)0.70x

Discussion

No comments yet — be the first to weigh in on OCS.

Leave a comment

Scroll to Top